You can track all bills at https://legiscan.com/FL. These are the top issues we are following:
Updated as of February 4, 2016
Electrology/Laser Hair Removal
HB 591 by Rep. Holly Raschein
SB 504 by Senator Denise Grimsley
- SUMMARY - the underlying issue of the original filed language was not problematic as it only sought to require licensed electrologists to be certified by a national organization and have appropriate training.
- The Senate version passed clean through all its committees of reference and is ready for the consideration of the full Senate.
- The House version, HB 591, was scheduled for the House Health Quality Subcommittee this past Tuesday. As we have already communicated, we were successful in defeating a harmful amendment sponsored by Rep. Greg Steube that would change the supervision of electrologists from DIRECT to INDIRECT physician supervision. This bill was ultimately temporarily postponed for consideration and the subcommittee does not plan to meet anymore this session. From a process perspective, this kills the bill.
HB 1217 by Rep. Geller
SB 974 by Senator Eleanor Sobel
- SUMMARY – This legislation would prohibit persons (besides MDs, Dos, PAs and ARNPs) from performing hair transplant procedures.
- The House version received its first hearing this past Tuesday in the House Health Quality Subcommittee and passed favorably. HB 1217 has two remaining committee references – the House Health Care Appropriations Subcommittee and the House Health and Human Services Committee.
- SB 974 passed its final committee of reference this morning – the Senate Fiscal Policy Committee. The committee adopted a late filed amendment (at the request of Senator Sobel) that added RNs to the list of those who could be involved in the transplant procedure. This bill is now ready for consideration by the full Senate.
SB 676 by Senator Denise Grimsley
HB 423 by Rep. Cary Pigman
- SUMMARY – this legislation provides for that PAs and ARNPs can prescribe controlled substances under their physician supervision/protocols.
- These bills are both teed up for successful passage. The Senate version, SB 676, has one remaining committee of reference – the Senate Appropriations Committee.
- The House bill has passed through all its committees of reference and is ready for consideration of the full House.
Fail First/Step Therapy
SB 1084 by Senator Don Gaetz
HB 963 by Rep. Shawn Harrison
- SUMMARY – the main focus of this legislation is to require insurers that restrict medications by a step-therapy or fail first protocol to have a clear override process by a physician.
- This legislation has been proposed for several years and has been unsuccessful.
- The Senate bill was considered and passed unanimously by the Senate Health Policy Committee on Monday.
- The House version, however, has not been considered to date. Its first committee of reference (total of three) will no longer be meeting for the duration of this legislative session. It appears that this bill may not pass but we will continue to monitor as other efforts may be taking place by stakeholders.
Treatments for Stable Patients
SB 1142 by Senator Alan Hays
HB 915 by Representative Debbie Mayfield
- SUMMARY – in brief, this would allow patients living with a complex or chronic medical condition or rare disease to continue to receive their brand drugs at a preferred cost for the calendar year.
- The Senate bill was considered favorably this past week in the Senate Banking and Insurance Committee with a unanimous vote. It has two remaining committees of reference, the Senate Health Policy Committee and the Senate Appropriations Committee.
- The House version, however, has not been considered to date. Its first committee of reference (total of three) will no longer be meeting for the duration of this legislative session. Similar to the fail first legislation, it appears that this bill may not pass but we will continue to monitor as other efforts may be taking place by stakeholders.